Early research (Phase 1)Looking for participantsNCT07563829
What this trial is testing
NPX372, a B7-H7:CD3 Bispecific Antibody, in Selected Solid Tumor Malignancies
Who this might be right for
Metastatic Malignant Neoplasm
NextPoint Therapeutics, Inc. 81